AP PHARMA INC /DE/

APPA

Insider trading at AP PHARMA INC /DE/

Transactions on record: 1,082; since Oct 9, 2003

Insider buys: 52; $68M

Insider sells: 86; $126M

Active insiders · 12 months: 11; last filing Jun 17, 2026

Figures computed from official regulatory filings — methodology.

Current insiders at AP PHARMA INC /DE/

14159 capital (GP), LLC10% owner
ADAM MICHAEL AChief Operating Officer
Baker Biotech Capital (GP), LLC10% owner
Baker Biotech Capital III (GP), LLC10% owner
Baker Bros. Capital (GP), LLC10% owner
BAKER FELIX10% owner
BAKER JULIAN10% owner
Baker / Tisch Capital (GP), LLC10% owner
BARR JOHNVice President of R&D
Christian WaageDirector
Clendeninn Neil JamesSVP & Chief Medical Officer
Collard Craig ADirector
Collard Craig AChief Executive Officer
Cusack ThomasDirector
DAVIS STEPHENDirector
DAVIS STEPHENChief Operating Officer
Dissanaike SharmilaDirector
Drazba Brian G.VP, Finance & CFO
DRURY STEPHEN ADirector
Duarte IraEVP, Chief Financial Officer
Forbes William PEVP, Chief Development Officer
Gelder Mark S. MDSVP & Chief Medical Officer
GODDARD PAULDirector
Hensley Mark EarlChief Operating Officer
HOFFMAN ROBERTCFO & SVP, Finance
Johnson Craig ADirector
Kaseta MichaelDirector
KOTLER KEVINDirector
MANHARD KIMBERLYDirector
MANHARD KIMBERLYEVP, Drug Development
Marshall PaulSVP, Technical Operations
Midler Andrew RExiting 10% holder
Midler Andrew R10% owner
Morgan AdamDirector
Morgan AdamSee Footnote 2
OCONNELL MICHAELChief Executive Officer
Peraza LisaVP, Chief Accounting Officer
PERCEPTIVE ADVISORS LLC10% owner
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD10% owner
POYHONEN JOHNDirector
POYHONEN JOHNPresident & CCO
PRENTKI RONALD JDirector
PRENTKI RONALD JPresident & CEO
Quart Barry DDirector
Quart Barry DChief Executive Officer
Retzios Anastassios D.VP of Clinical Development
RIEPENHAUSEN PETERDirector
Rodriguez SusanDirector
ROSENBLATT TOBYDirector
Rosen David EfraimSee Footnote 1
Rosen David Efraim10% owner
Rosen RobertDirector
Rosen RobertPresident
Rubric Capital Management LPSee Footnote 1
Rubric Capital Management LP10% owner
Savitr Capital, LLCExiting 10% holder
Savitr Capital, LLC10% owner
SPCH, LLLPExiting 10% holder
SPCH, LLLP10% owner
Szekeres David LeslieEVP, Chief Operating Officer
TANG CAPITAL MANAGEMENT LLCDirector
TANG CAPITAL MANAGEMENT LLC10% owner
TANG CAPITAL PARTNERS LPDirector
TANG CAPITAL PARTNERS LP10% owner
TANG KEVIN CDirector
TANG KEVIN CFormer Director
TANG KEVIN C10% owner
TAYLOR ARTHUR TDirector
TURNBULL GREGDirector
TURNBULL GREGCFO
Velan Capital Holdings LLCSee Footnote 2
Velan Capital Investment Management LPSee Footnote 2
Velan Capital Management LLCSee Footnote 2
Velan Capital Master Fund LPSee Footnote 2
VENKATARAMAN BALAJISee Footnote 2
Whelan JohnDirector
Whelan JohnCFO
WHITEFORD STEPHENV.P., Finance & CFO
WINGER DENNIS LDirector
ZERBE ROBERT L MDDirector

Insider	Filed	Type	Qty	Price	Value · USD	Src
Duarte Ira	Jun 17, 2026	ExerciseD	-12,500	0.00 USD	—	SEC
Duarte Ira	Jun 17, 2026	Exercise	12,500	—	—	SEC
Duarte Ira	Jun 17, 2026	Other	-3,555	0.38 USD	—	SEC
Forbes William P	Jun 8, 2026	Exercise	12,500	—	—	SEC
Forbes William P	Jun 8, 2026	ExerciseD	-12,500	0.00 USD	$0	SEC
Hensley Mark Earl	May 7, 2026	ExerciseD	-125,000	0.00 USD	$0	SEC
Hensley Mark Earl	May 7, 2026	Exercise	125,000	—	—	SEC
Collard Craig A	May 4, 2026	Exercise	34,789	—	—	SEC
Hensley Mark Earl	May 4, 2026	Exercise	11,770	—	—	SEC
Forbes William P	May 4, 2026	Exercise	11,694	—	—	SEC
Duarte Ira	May 4, 2026	Exercise	11,694	—	—	SEC
Duarte Ira	May 4, 2026	ExerciseD	-11,694	0.00 USD	$0	SEC
Forbes William P	May 4, 2026	ExerciseD	-11,770	0.00 USD	$0	SEC
Hensley Mark Earl	May 4, 2026	ExerciseD	-11,770	0.00 USD	$0	SEC
Collard Craig A	May 4, 2026	ExerciseD	-50,021	0.00 USD	$0	SEC
Duarte Ira	May 4, 2026	Exercise	13,535	—	—	SEC
Forbes William P	May 4, 2026	Exercise	11,770	—	—	SEC
Collard Craig A	May 4, 2026	ExerciseD	-34,789	0.00 USD	$0	SEC
Duarte Ira	May 4, 2026	ExerciseD	-13,535	0.00 USD	$0	SEC
Forbes William P	May 4, 2026	ExerciseD	-11,694	0.00 USD	$0	SEC
Collard Craig A	May 4, 2026	Exercise	50,021	—	—	SEC
Forbes William P	Apr 21, 2026	Exercise	3,874	—	—	SEC
Forbes William P	Apr 21, 2026	ExerciseD	-3,874	0.00 USD	$0	SEC
Collard Craig A	Apr 21, 2026	Exercise	13,797	—	—	SEC
Duarte Ira	Apr 21, 2026	Exercise	3,874	—	—	SEC

Insider	Filed	Type	Qty	Price	Value · USD	Src
Duarte Ira	Jun 17, 2026	ExerciseD	-12,500	0.00 USD	—	SEC
Duarte Ira	Jun 17, 2026	Exercise	12,500	—	—	SEC
Duarte Ira	Jun 17, 2026	Other	-3,555	0.38 USD	—	SEC
Forbes William P	Jun 8, 2026	Exercise	12,500	—	—	SEC
Forbes William P	Jun 8, 2026	ExerciseD	-12,500	0.00 USD	$0	SEC
Hensley Mark Earl	May 7, 2026	ExerciseD	-125,000	0.00 USD	$0	SEC
Hensley Mark Earl	May 7, 2026	Exercise	125,000	—	—	SEC
Collard Craig A	May 4, 2026	Exercise	34,789	—	—	SEC
Hensley Mark Earl	May 4, 2026	Exercise	11,770	—	—	SEC
Forbes William P	May 4, 2026	Exercise	11,694	—	—	SEC
Duarte Ira	May 4, 2026	Exercise	11,694	—	—	SEC
Duarte Ira	May 4, 2026	ExerciseD	-11,694	0.00 USD	$0	SEC
Forbes William P	May 4, 2026	ExerciseD	-11,770	0.00 USD	$0	SEC
Hensley Mark Earl	May 4, 2026	ExerciseD	-11,770	0.00 USD	$0	SEC
Collard Craig A	May 4, 2026	ExerciseD	-50,021	0.00 USD	$0	SEC
Duarte Ira	May 4, 2026	Exercise	13,535	—	—	SEC
Forbes William P	May 4, 2026	Exercise	11,770	—	—	SEC
Collard Craig A	May 4, 2026	ExerciseD	-34,789	0.00 USD	$0	SEC
Duarte Ira	May 4, 2026	ExerciseD	-13,535	0.00 USD	$0	SEC
Forbes William P	May 4, 2026	ExerciseD	-11,694	0.00 USD	$0	SEC
Collard Craig A	May 4, 2026	Exercise	50,021	—	—	SEC
Forbes William P	Apr 21, 2026	Exercise	3,874	—	—	SEC
Forbes William P	Apr 21, 2026	ExerciseD	-3,874	0.00 USD	$0	SEC
Collard Craig A	Apr 21, 2026	Exercise	13,797	—	—	SEC
Duarte Ira	Apr 21, 2026	Exercise	3,874	—	—	SEC

AP PHARMA INC /DE/

Insider trading at AP PHARMA INC /DE/

Current insiders at AP PHARMA INC /DE/

AP PHARMA INC /DE/

Insider trading at AP PHARMA INC /DE/

Current insiders at AP PHARMA INC /DE/

Insider transaction history at AP PHARMA INC /DE/

Insider transaction history at AP PHARMA INC /DE/